Browse

“It is important to create barriers between high intensity shifts with physical, intellectual, and emotional burden to avoid burnout” in residents, writes Arifeen Rahman.

State fights over issues like transgender rights and Medicaid offer clues to where Americans stand on contentious health matters.

Gilead Sciences reported results from a Phase 2 trial of its oral ulcerative colitis drug emvistegrast. In the study, patients took a 200 mg daily dose for 12 weeks and achieved a 23% placebo-adju…